NASHUA, N.H., March 26, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer
detection and therapy solutions, today announced that Michael Klein, Chief Executive Officer, and Stacey Stevens, Chief Strategy &
Commercial Officer, will be present a corporate overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics
Summit, being held March 27 in New York City.
| Presentation Details: |
| Date: |
Wednesday, March 27 |
| Time: |
2:00pm Eastern Time |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and
therapy solutions. For more information, visit www.icadmed.com.
Contact:
Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com
or:
Media Inquiries:
ARPR, on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
paul@arpr.com
